Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Total Non-Current Liabilities (2024 - 2025)

Greenwich LifeSciences filings provide 2 years of Total Non-Current Liabilities readings, the most recent being $1.4 million for Q2 2025.

  • Quarterly Total Non-Current Liabilities changed N/A to $1.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Jun 2025, changed N/A year-over-year, with the annual reading at $1.3 million for FY2024, N/A changed from the prior year.
  • Total Non-Current Liabilities hit $1.4 million in Q2 2025 for Greenwich LifeSciences, up from $1.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.4 million in Q2 2025 and bottomed at $1.1 million in Q1 2025.